Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up 1842 News Items found FDA Announces First Approval of Targeted Therapy Based on Basket Study Monday, November 6, 2017 The US Food and Drug Administration (FDA) has announced that it has approved the drug vemurafenib for the treatment of patients with BRAF V600-mutant Erdheim-Chester disease (ECD). This is the first approval of a targeted therapy based on a basket study and the first-ever drug approved for ECD, a rare blood disorder. This landmark approval came as a direct result of research at Memorial Sloan Kettering Cancer Center (MSK). In the Lab MSK-Developed Technology Provides a “Virtual Biopsy” of Immune Cells in Tumors Thursday, November 2, 2017 The noninvasive approach could help scientists track the movements of an important cell type that can influence the outcome of cancer treatment. Science Byte Blocking Enzymes That Signal DNA Damage Could Be a Treatment Strategy for Childhood Cancers Wednesday, November 1, 2017 A new strategy for treating pediatric cancers involves preventing cells from repairing their own DNA. Event Why They Run: Fred’s Team Runners Take on the 2017 TCS New York City Marathon Tuesday, October 31, 2017 Hear from five Fred’s Team members about why they’re running the New York City Marathon in 2017. Q&A How Meditation Can Help Those Affected by Cancer: At Work with Emily Herzlin Wednesday, October 25, 2017 Meet Emily Herzlin, who teaches mindfulness and meditation at Memorial Sloan Kettering. Finding Myeloma Precursor Disease Can Start Much Earlier than Expected, Especially in African Americans Monday, October 23, 2017 New research has found that a precancerous blood condition can linger undetected for more than 20 years. Announcement FDA Approves CAR T Cell Therapy for Non-Hodgkin Lymphoma Thursday, October 19, 2017 This is the second regulatory approval of the cell-based immunotherapy for a blood cancer. In the Lab Stem Cell Research Probes Why a Breast Cancer Treatment Sometimes Damages the Heart Thursday, October 19, 2017 Investigators are looking at how and why the breast cancer drug trastuzumab sometimes causes long-lasting and potentially serious cardiac side effects. Q&A The Benefits of a Metastatic Breast Cancer Support Group: An Interview with a Social Worker Tuesday, October 17, 2017 Learn how a support group could help you if you’ve been diagnosed with metastatic breast cancer. In the Lab Research Reveals How Sleeping Cancer Cells Wake Up Thursday, October 12, 2017 MSK investigators are studying how dormant cancer cells can become reactivated after remaining hidden in the body for years. Pagination Load More Book traversal links for Newsroom Previous Newsroom Next Cancer Vaccine Could Prevent Neuroblastoma From Returning After Antibody Treatment